Office of the Director, National Institutes of Health; Notice of Meeting, 44575-44576 [2013-17697]
Download as PDF
<![CDATA[
44575
Federal Register / Vol. 78, No. 142 / Wednesday, July 24, 2013 / Notices
Dated: July 19, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–17769 Filed 7–23–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Sickle Cell Disease Treatment
Demonstration Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Request for Class Deviation for
Non-Competitive Extension: Sickle Cell
Disease Treatment Demonstration
Program (U1E) Awards to Three
Currently Funded Grantees.
AGENCY:
HRSA currently has nine
programs that are funded through
competitive grant awards under the
Sickle Cell Disease Treatment
Demonstration Program. Three of these
SUMMARY:
awards will end on August 31, 2013,
prior to the end of the other six awards.
HRSA intends to implement a noncompetitive extension of the project
period for the three grants that will end
in 2013. This will allow improved data
gathering from each of the grantees in
the program, which will be used in a
report for Congress that is mandated by
the legislation authorizing the grant. In
addition, the program will benefit from
cost savings realized from having the
program completed in a consolidated
funding cycle.
SUPPLEMENTARY INFORMATION:
Intended Recipients of the Award:
The three incumbent grantees of record
(listed below).
Amount of the Non-Competitive
Awards: Up to $390,000 per grantee.
CFDA Number: 93.365.
Period of Supplemental Funding: 9/1/
2013–8/30/2014.
Authority: Section 712(c) of the American
Jobs Creation Act of 2004, Pub. L. 108–357.
Justification: The Sickle Cell Disease
Treatment Demonstration Program
provides grants to evaluate the use of
strategies in improving sickle cell care.
The extension will allow the Maternal
and Child Health Bureau to fully assess
the impact of the program by allowing
data to be gathered on the health
outcomes and impact of the Sickle Cell
Disease Treatment Demonstration
Program from all grantees on the same
timeline and in a standard format.
Currently, three grantees are scheduled
to end prior to the end of the other
grantees, leaving a period in which data
would not be gathered from these sites.
Data gathered from each of the grantees
in the program will be used in a report
for Congress that is mandated by the
legislation authorizing the grant. In
addition, the program will benefit from
cost savings realized from having the
program completed in a consolidated
funding cycle.
FOR FURTHER INFORMATION CONTACT:
Edward Donnell Ivy, M.D., M.P.H,
Genetic Services Branch, Division of
Services for Children with Special
Health Needs, Maternal and Child
Health Bureau, Health Resources and
Services Administration, 5600 Fishers
Lane, Room 18A–19, Rockville, MD
20857; 301.443.9775; eivy@hrsa.gov.
MATERNAL AND CHILD HEALTH BUREAU SELECTED PROGRAMS EXTENSIONS WITH FUNDING
Project end
date
Revised
project end
date
FY 2012
Appropriation
FY 2013
Appropriation
Grant No.
Children’s Hospital & Research
Center.
University of Colorado at Denver.
Newark Beth Israel Medical
Center.
U1EMC16492
CA
9/1/2009
8/31/2013
8/30/2014
$390,000
$390,000
U1EMC16490
CO
9/1/2009
8/31/2013
8/30/2014
390,000
390,000
U1EMC16491
NJ
9/1/2009
8/31/2013
8/30/2014
390,000
390,000
Dated: July 17, 2013.
Mary K. Wakefield,
Administrator.
[FR Doc. 2013–17720 Filed 7–23–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on DSK5SPTVN1PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
Council of Councils.
The meeting will be held via
teleconference and is open to the public
as indicated below. Individuals who
need special assistance, such as sign
language interpretation or other
VerDate Mar<15>2010
16:35 Jul 23, 2013
Jkt 229001
State
Project start
date
Grantee/organization name
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: August 15, 2013, 1:00 p.m. to 1:40
p.m.
Agenda: Establishment of Chimpanzee
Research Use Panel and Discussion. Vote on
Establishment of the Panel. NIH Director’s
Early Independence Awards.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Building 1, Room 260, 1 Center Drive,
Bethesda, MD 20892.
Dial in number: 1–888–790–1964.
Participant Passcode: 9121608.
Closed: August 15, 2013, 1:45 p.m. to 2:15
p.m.
Agenda: Review of Grant Applications.
Contact Person: Robin Kawazoe, Executive
Secretary, Division of Program Coordination,
Planning, and Strategic Initiatives, Office of
the Director, NIH, Building 1, Room 260,
Bethesda, MD 20892,
kawazoer@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the Council
of Council’s home page at https://
dpcpsi.nih.gov/council/where an agenda and
proposals to be discussed will be posted
before the meeting date.
E:\FR\FM\24JYN1.SGM
24JYN1
44576
Federal Register / Vol. 78, No. 142 / Wednesday, July 24, 2013 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: July 17, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17697 Filed 7–23–13; 8:45 am]
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: July 18, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17696 Filed 7–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Amended
Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, July 22,
2013, 8:00 a.m. to July 23, 2013, 5:00
p.m., National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on June 28, 2013, 78 FR Page
38999.
The meeting will be held on August
7–8 2013 instead of July 22–23 2013 at
8:00 a.m. and will end at 5:00 p.m. The
meeting location remains the same. The
meeting is closed to the public.
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
sroberts on DSK5SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Newborn Screening
Transitional Research Network.
Date: August 5, 2013.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680,
skandasa@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
VerDate Mar<15>2010
16:35 Jul 23, 2013
Jkt 229001
Dated: July 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17695 Filed 7–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ZHD1 DSR–Z 50 1.
Date: August 13, 2013.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division Of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6902, peter.zelazowski@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ZHD1 DSR–H GS 1.
Date: August 15, 2013.
Time: 3:15 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6911, hopmannm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: July 18, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–17694 Filed 7–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\24JYN1.SGM
24JYN1
]]>Agencies
[Federal Register Volume 78, Number 142 (Wednesday, July 24, 2013)]
[Notices]
[Pages 44575-44576]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17697]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the Council of Councils.
The meeting will be held via teleconference and is open to the
public as indicated below. Individuals who need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4), and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such
as patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Council of Councils.
Open: August 15, 2013, 1:00 p.m. to 1:40 p.m.
Agenda: Establishment of Chimpanzee Research Use Panel and
Discussion. Vote on Establishment of the Panel. NIH Director's Early
Independence Awards.
Place: National Institutes of Health, Building 1, Room 260, 1
Center Drive, Bethesda, MD 20892.
Dial in number: 1-888-790-1964.
Participant Passcode: 9121608.
Closed: August 15, 2013, 1:45 p.m. to 2:15 p.m.
Agenda: Review of Grant Applications.
Contact Person: Robin Kawazoe, Executive Secretary, Division of
Program Coordination, Planning, and Strategic Initiatives, Office of
the Director, NIH, Building 1, Room 260, Bethesda, MD 20892,
kawazoer@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person. Information is also available
on the Council of Council's home page at https://dpcpsi.nih.gov/council/where an agenda and proposals to be discussed will be posted
before the meeting date.
[[Page 44576]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: July 17, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-17697 Filed 7-23-13; 8:45 am]
BILLING CODE 4140-01-P
